Cognitive Neuroscience

Jan 8, 2025 | link.springer.com | Cognitive Neuroscience

AbstractApraxia is a motor-cognitive disorder that primary sensorimotor deficits cannot solely explain. Previous research in stroke patients has focused on damage to the fronto-parietal praxis networks in the left hemisphere (LH) as the cause of apraxic deficits. In contrast, the potential role of the (left) primary motor cortex (M1) has largely been neglected.

Oct 2, 2024 | onlinelibrary.wiley.com | Wei Lu |Cognitive Neuroscience |Huayu Ji |Yiji Wang

CONFLICT OF INTEREST STATEMENT The authors declare there is no conflict of interest. REFERENCES (2017). Psychological maltreatment, coping strategies, and mental health problems: A brief and effective measure of psychological maltreatment in adolescents. Child Abuse & Neglect, 68, 96–106. https://doi.org/10.1016/j.chiabu.2017.03.023 , , , & (2003). Avoidant coping as a mediator between self-reported sexual abuse and stress-related symptoms in adolescents.

Sep 13, 2024 | link.springer.com | Cognitive Neuroscience

AbstractB-cell-targeting monoclonal antibodies have demonstrated safety and efficacy in multiple sclerosis or anti-aquaporin-4 IgG positive neuromyelitis optica spectrum disorder. However, these therapies do not facilitate drug-free remission, which may become possible with cell-based therapies, including chimeric antigen receptor (CAR) T cells. CAR T-cell therapy holds promise for addressing other antibody-mediated CNS disorders, e.g., MOG-associated disease or autoimmune encephalitis.

Sep 10, 2024 | academic.oup.com | Cognitive Neuroscience

Social hierarchy is a typical feature of social organization. The ability to quickly recognize social hierarchy information is crucial for adapting to social contexts. Here, we adopted fast periodic visual stimulation (FPVS) with electroencephalography (EEG) to assess the neural responses to social hierarchy during social competition and cooperation, respectively. Participants first learned hierarchical faces from a competitive game versus a cooperative game.

Apr 23, 2024 | link.springer.com | Cognitive Neuroscience

AbstractThis case series reports clinical features and outcome of four patients with non-systemic vasculitic neuropathy (NSVN) treated with the anti-CD20 agent rituximab. Clinical, electrophysiological and biopsy data were retrospectively obtained and evaluated. Only patients with pathological definite or probable NSVN were included. Extensive clinical and laboratory work-up excluded systemic vasculitis. Follow-up data for at least 12 months and up to five years is provided.